237 related articles for article (PubMed ID: 19731236)
1. Differential effects of progressive familial intrahepatic cholestasis type 1 and benign recurrent intrahepatic cholestasis type 1 mutations on canalicular localization of ATP8B1.
Folmer DE; van der Mark VA; Ho-Mok KS; Oude Elferink RP; Paulusma CC
Hepatology; 2009 Nov; 50(5):1597-605. PubMed ID: 19731236
[TBL] [Abstract][Full Text] [Related]
2. Folding defects in P-type ATP 8B1 associated with hereditary cholestasis are ameliorated by 4-phenylbutyrate.
van der Velden LM; Stapelbroek JM; Krieger E; van den Berghe PV; Berger R; Verhulst PM; Holthuis JC; Houwen RH; Klomp LW; van de Graaf SF
Hepatology; 2010 Jan; 51(1):286-96. PubMed ID: 19918981
[TBL] [Abstract][Full Text] [Related]
3. The lipid flippase heterodimer ATP8B1-CDC50A is essential for surface expression of the apical sodium-dependent bile acid transporter (SLC10A2/ASBT) in intestinal Caco-2 cells.
van der Mark VA; de Waart DR; Ho-Mok KS; Tabbers MM; Voogt HW; Oude Elferink RP; Knisely AS; Paulusma CC
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2378-86. PubMed ID: 25239307
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Adenosine Triphosphatase Phospholipid Transporting 8B1 (ATP8B1) Function in Patients With Cholestasis With ATP8B1 Deficiency by Using Peripheral Blood Monocyte-Derived Macrophages.
Mizutani A; Sabu Y; Naoi S; Ito S; Nakano S; Minowa K; Mizuochi T; Ito K; Abukawa D; Kaji S; Sasaki M; Muroya K; Azuma Y; Watanabe S; Oya Y; Inomata Y; Fukuda A; Kasahara M; Inui A; Takikawa H; Kusuhara H; Bessho K; Suzuki M; Togawa T; Hayashi H
Hepatol Commun; 2021 Jan; 5(1):52-62. PubMed ID: 33437900
[TBL] [Abstract][Full Text] [Related]
5. ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity.
Paulusma CC; Folmer DE; Ho-Mok KS; de Waart DR; Hilarius PM; Verhoeven AJ; Oude Elferink RP
Hepatology; 2008 Jan; 47(1):268-78. PubMed ID: 17948906
[TBL] [Abstract][Full Text] [Related]
6. Case Report: A Rare Heterozygous
Bing H; Li YL; Li D; Zhang C; Chang B
Front Med (Lausanne); 2022; 9():897108. PubMed ID: 35783636
[TBL] [Abstract][Full Text] [Related]
7. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
Davit-Spraul A; Fabre M; Branchereau S; Baussan C; Gonzales E; Stieger B; Bernard O; Jacquemin E
Hepatology; 2010 May; 51(5):1645-55. PubMed ID: 20232290
[TBL] [Abstract][Full Text] [Related]
8. Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport.
Paulusma CC; Groen A; Kunne C; Ho-Mok KS; Spijkerboer AL; Rudi de Waart D; Hoek FJ; Vreeling H; Hoeben KA; van Marle J; Pawlikowska L; Bull LN; Hofmann AF; Knisely AS; Oude Elferink RP
Hepatology; 2006 Jul; 44(1):195-204. PubMed ID: 16799980
[TBL] [Abstract][Full Text] [Related]
9. ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained.
Cai SY; Gautam S; Nguyen T; Soroka CJ; Rahner C; Boyer JL
Gastroenterology; 2009 Mar; 136(3):1060-9. PubMed ID: 19027009
[TBL] [Abstract][Full Text] [Related]
10. Rescue of defective ATP8B1 trafficking by CFTR correctors as a therapeutic strategy for familial intrahepatic cholestasis.
van der Woerd WL; Wichers CG; Vestergaard AL; Andersen JP; Paulusma CC; Houwen RH; van de Graaf SF
J Hepatol; 2016 Jun; 64(6):1339-47. PubMed ID: 26879107
[TBL] [Abstract][Full Text] [Related]
11. FIC1-mediated stimulation of FXR activity is decreased with PFIC1 mutations in HepG2 cells.
Koh S; Takada T; Kukuu I; Suzuki H
J Gastroenterol; 2009; 44(6):592-600. PubMed ID: 19381753
[TBL] [Abstract][Full Text] [Related]
12. ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy.
Müllenbach R; Bennett A; Tetlow N; Patel N; Hamilton G; Cheng F; Chambers J; Howard R; Taylor-Robinson SD; Williamson C
Gut; 2005 Jun; 54(6):829-34. PubMed ID: 15888793
[TBL] [Abstract][Full Text] [Related]
13. ATP8B1 and ATP11C: Two Lipid Flippases Important for Hepatocyte Function.
Naik J; de Waart DR; Utsunomiya K; Duijst S; Mok KH; Oude Elferink RP; Bosma PJ; Paulusma CC
Dig Dis; 2015; 33(3):314-8. PubMed ID: 26045263
[TBL] [Abstract][Full Text] [Related]
14. Hepatic cytochrome P450 deficiency in mouse models for intrahepatic cholestasis predispose to bile salt-induced cholestasis.
Kunne C; de Graaff M; Duijst S; de Waart DR; Oude Elferink RP; Paulusma CC
Lab Invest; 2014 Oct; 94(10):1103-13. PubMed ID: 25068656
[TBL] [Abstract][Full Text] [Related]
15. FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte.
Eppens EF; van Mil SW; de Vree JM; Mok KS; Juijn JA; Oude Elferink RP; Berger R; Houwen RH; Klomp LW
J Hepatol; 2001 Oct; 35(4):436-43. PubMed ID: 11682026
[TBL] [Abstract][Full Text] [Related]
16. Abcg5/8 independent biliary cholesterol excretion in Atp8b1-deficient mice.
Groen A; Kunne C; Jongsma G; van den Oever K; Mok KS; Petruzzelli M; Vrins CL; Bull L; Paulusma CC; Oude Elferink RP
Gastroenterology; 2008 Jun; 134(7):2091-100. PubMed ID: 18466903
[TBL] [Abstract][Full Text] [Related]
17. Progressive familial intrahepatic cholestasis type 1.
Paulusma CC; Elferink RP; Jansen PL
Semin Liver Dis; 2010 May; 30(2):117-24. PubMed ID: 20422494
[TBL] [Abstract][Full Text] [Related]
18. Phospholipid flippase activities and substrate specificities of human type IV P-type ATPases localized to the plasma membrane.
Takatsu H; Tanaka G; Segawa K; Suzuki J; Nagata S; Nakayama K; Shin HW
J Biol Chem; 2014 Nov; 289(48):33543-56. PubMed ID: 25315773
[TBL] [Abstract][Full Text] [Related]
19. The phospholipid flippase ATP8B1 mediates apical localization of the cystic fibrosis transmembrane regulator.
van der Mark VA; de Jonge HR; Chang JC; Ho-Mok KS; Duijst S; Vidović D; Carlon MS; Oude Elferink RP; Paulusma CC
Biochim Biophys Acta; 2016 Sep; 1863(9):2280-8. PubMed ID: 27301931
[TBL] [Abstract][Full Text] [Related]
20. Heteromeric interactions required for abundance and subcellular localization of human CDC50 proteins and class 1 P4-ATPases.
van der Velden LM; Wichers CG; van Breevoort AE; Coleman JA; Molday RS; Berger R; Klomp LW; van de Graaf SF
J Biol Chem; 2010 Dec; 285(51):40088-96. PubMed ID: 20947505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
